Rehabilitation of eosinophilic fasciitis. A case report.
Eosinophilic fasciitis (EF), first described in 1974, is characterized by the sudden onset of painful swelling with induration of the soft tissues and peripheral eosinophilia, often after an episode of intense physical exertion. It rapidly progresses to joint contractures because of inflammation and fibrosis of the fascia. Of the 200 cases reported in the medical literature, most have responded positively to a prolonged course of oral prednisone. Although complete recovery is possible, more frequently signs and symptoms of EF persist. There were no detailed descriptions found in the literature of any rehabilitative interventions in this disease. This case study describes the methods used in a successful, comprehensive rehabilitation treatment of a 21-yr-old man admitted to the Palo Alto VA Medical Center rehabilitation program 8 mo after the onset of symptoms. Previous medication therapy included prednisone and methotrexate. The patient underwent 2 mo of inpatient rehabilitation, which consisted of upper and lower extremity nerve blocks, serial splinting, application of physical modalities, massage, stretching and strengthening exercises and interdisciplinary pain management. Significant improvement was made in the range of motion in all extremities, strength, hand function, level of pain, gait and endurance. Aggressive therapy did not increase eosinophilia. In fact the eosinophil count returned to normal by the time of discharge. A detailed review of the patient's rehabilitation program is presented.
O'Laughlin
T J
TJ
Department of Functional Restoration, Stanford University Medical Center, California.
Klima
R R
RR
Kenney
D E
DE
D000203:Activities of Daily Living; D000328:Adult; D003286:Contracture / Q000517:prevention & control; D004802:Eosinophilia / Q000150:complications*; D005208:Fasciitis / Q000150:complications / Q000534:rehabilitation* / Q000628:therapy; D005684:Gait; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D010146:Pain / Q000517:prevention & control; D011241:Prednisone / Q000627:therapeutic use; D016059:Range of Motion, Articular
D011241:Prednisone; D008727:Methotrexate